Table 1 Comparison of clinical data between the 2 groups
Factor | Characteristics | Combined group(186) | Non-combined group(299) | χ2/t/Z | P | |
|---|---|---|---|---|---|---|
Gender | M | 26(13.98) | 75(25.08) | 0.739 | 0.604 | |
F | 160(86.02 | 224(74.92) | ||||
Age (Years) | 41.15 ± 12.54 | 45.94 ± 13.33 | 1.904 | 0.077 | ||
Site of disease | Left year | 49(29.07) | 85(28.43) | 7.306 | 0.136 | |
Right year | 112(60.22) | 175(58.53) | ||||
Both years | 25(13.44) | 39(13.04) | ||||
TEQ grade | I | 24(12.90) | 37(12.37) | 0.804 | 0.394 | |
II | 48(25.81) | 74(24.75) | ||||
III | 53(28.49) | 96(32.11) | ||||
IV | 41(22.04) | 63(21.07) | ||||
V | 20(10.75) | 29(9.70) | ||||
PT characteristics | Persistent PT | 47(25.27) | 82(27.42) | 0.523 | 0.085 | |
Intermittent PT | 139(74.73) | 217(72.58) | ||||
Duration of disease(Month) | 11.00(3.00,34.00) | 9.00(1.00,20.00) | -1.903 | 0.063 | ||
Accompanying symptoms | No | 32(17.20) | 72(24.08) | 1.603 | 0.045 | |
Headache or dizziness | 23(12.37) | 42(14.05) | 0.405 | 0.085 | ||
Ocular symptoms | 37(19.89) | 63(21.07) | 0.325 | 0.791 | ||
Hearing loss | 82(44.09) | 105(35.12) | 0.703 | 0.352 | ||
Others | 12(6.45) | 17(5.69) | 0.631 | 0.319 | ||